Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Madisonian.net
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: Madisonian.netLaw Review Submission Stories
By Mike Madison
Dave Hoffman at CoOp has opened the bidding on law review spring submission stories. Here is a slightly different perspective.
Last year I became one of our (Pittsburgh’s) advisors to the law review. One of the things that I noticed at the time was the difference between Pitt’s US News ranking (a not entirely meaningless number, because among other things many law profs use US News ranking as a proxy for law review prestige when submitting manuscripts) and Pitt’s ranking in the Washington & Lee Law Journal Submission/Ranking index. If one assumes that the two ranks should be more or less equivalent — an interesting proposition to debate, in itself — then Pitt had (and still has) a problem.
As part of thinking about how the law review and the law school might respond, I looked into how the review selects articles. What I learned more or less confirmed some conventional wisdom. The accepted learning among the students, passed down from board to board, is that the review should steer clear of anything “theoretical.” Practical, detailed, problem-solving pieces are the coin of the realm — because, I learned, this sort of work is more likely to be cited by future scholars and by courts.
My two cents was to suggest that the review might expand its horizons a bit. Even in a middle market journal, theory has a place, and theory can have an impact. That’s my bias as a writer, too, and I know that if the students try to implement my suggestion to any degree, I have probably bought myself additional work helping them sort wheat from chaff. Our law school isn’t big on teaching theory in the first place.
No Tags
Full post as published by Madisonian.net on March 09, 2009 (boomark / email).
FDA Issues Update on Safety Review Orlistat
Orlistat FDA Issues Update on Safety Review
Aurora Loan Faces Class Action over Mortgage Review Services
Aurora Loan Faces Class Action over Mortgage Review Services
FDA Review of Prostate Cancer Treatment Prompts Warning of Risk for Diabetes
Prostate Cancer Treatment FDA Review Prompts Warning of Risk for Diabetes
Xigris
Study Prompts FDA Safety Review
Lipitor
Review of Studies Show No Significant Benefit in Women
Wrinkle-Fillers
FDA to Review Labeling due to Adverse Event Reports

Law Review Submission Season Stories of Inspiration: Written Apology from YLJ!
Using ExpressO to Implement Law Review Submission Reform
Is the Window Open February Law Review Submission Season Notice Board
Article Submission Season & ExpressO
Update: YLJ Submission Policy Revealed








